Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $960.95 | 65 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $163.28 | 13 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $123.56 | 8 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $106.24 | 6 | $0 (2020) |
| Novo Nordisk Inc | $92.83 | 6 | $0 (2020) |
| PFIZER INC. | $80.75 | 7 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $80.06 | 5 | $0 (2018) |
| Amgen Inc. | $78.06 | 4 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $55.48 | 4 | $0 (2018) |
| GlaxoSmithKline, LLC. | $37.15 | 2 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $28.96 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $152.53 | 10 | AstraZeneca Pharmaceuticals LP ($54.28) |
| 2019 | $206.15 | 13 | Novartis Pharmaceuticals Corporation ($58.41) |
| 2018 | $234.74 | 16 | Janssen Pharmaceuticals, Inc ($66.05) |
| 2017 | $367.53 | 26 | SANOFI-AVENTIS U.S. LLC ($65.29) |
All Payment Transactions
65 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/13/2020 | PFIZER INC. | CHANTIX (Drug), COLOGUARD | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 03/11/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/04/2020 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Diabetes | ||||||
| 02/26/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Diabetes | ||||||
| 02/26/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $11.29 | General |
| Category: Respiratory | ||||||
| 02/19/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: Respiratory | ||||||
| 02/12/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/05/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/04/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, SYNJARDY XR | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: DIABETES | ||||||
| 01/08/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Diabetes | ||||||
| 12/10/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/03/2019 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 11/19/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/31/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/09/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/25/2019 | GENZYME CORPORATION | LEMTRADA (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 09/04/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/10/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Neuroscience | ||||||
| 05/29/2019 | PFIZER INC. | EUCRISA (Drug), COLOGUARD | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: DERMATOLOGY | ||||||
| 04/09/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/20/2019 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: DERMATOLOGY | ||||||
| 02/08/2019 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: Bone Health | ||||||
| 02/06/2019 | Novo Nordisk Inc | Tresiba (Drug), Victoza, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Diabetes | ||||||
| 12/19/2018 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/17/2018 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 330 | 351 | $43,874 | $21,660 |
| 2022 | 8 | 673 | 809 | $98,524 | $52,267 |
| 2021 | 9 | 690 | 816 | $119,308 | $43,419 |
| 2020 | 13 | 1,127 | 1,375 | $177,915 | $50,095 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 96 | 96 | $25,248 | $12,520 | 49.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 150 | 170 | $15,898 | $8,043 | 50.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 27 | 28 | $1,708 | $822.07 | 48.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 45 | 45 | $900.00 | $165.07 | 18.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 12 | 12 | $120.00 | $109.92 | 91.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 197 | 197 | $51,811 | $25,758 | 49.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 254 | 371 | $35,045 | $20,628 | 58.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 89 | 105 | $7,021 | $3,719 | 53.0% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 11 | 12 | $1,900 | $1,094 | 57.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 12 | 14 | $798.00 | $524.56 | 65.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 86 | 86 | $1,720 | $412.01 | 24.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 13 | 13 | $130.00 | $118.95 | 91.5% |
| G0405 | Electrocardiogram, routine ecg with 12 leads; interpretation and report only, performed as a screening for the initial preventive physical examination | Office | 2022 | 11 | 11 | $99.00 | $13.28 | 13.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 184 | 184 | $48,392 | $24,571 | 50.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 207 | 298 | $46,164 | $11,777 | 25.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 122 | 150 | $17,004 | $4,531 | 26.6% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 13 | 13 | $3,032 | $1,630 | 53.8% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2021 | 60 | 61 | $1,220 | $335.00 | 27.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 12 | 12 | $608.00 | $191.33 | 31.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 47 | 53 | $1,325 | $151.20 | 11.4% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 16 | 16 | $432.00 | $148.00 | 34.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 29 | 29 | $1,131 | $83.93 | 7.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 183 | 183 | $48,129 | $21,442 | 44.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 212 | 312 | $76,440 | $13,582 | 17.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 105 | 142 | $23,856 | $4,530 | 19.0% |
About Dr. R. Winkel, M.D
Dr. R. Winkel, M.D is a Pediatrics healthcare provider based in Kalispell, Montana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740225333.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. R. Winkel, M.D has received a total of $960.95 in payments from pharmaceutical and medical device companies, with $152.53 received in 2020. These payments were reported across 65 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($960.95).
As a Medicare-enrolled provider, Winkel has provided services to 2,820 Medicare beneficiaries, totaling 3,351 services with total Medicare billing of $167,440. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Pediatrics
- Other Specialties Family Medicine
- Location Kalispell, MT
- Active Since 06/18/2006
- Last Updated 11/27/2023
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1740225333
Products in Payments
- TOUJEO (Drug) $106.88
- FARXIGA (Drug) $93.15
- ENTRESTO (Drug) $75.02
- SYMBICORT (Drug) $70.13
- Prolia (Biological) $59.73
- XARELTO (Drug) $53.11
- EUCRISA (Drug) $46.37
- Ozempic (Drug) $33.76
- Tresiba (Drug) $31.29
- COSENTYX (Biological) $31.22
- JANUVIA (Drug) $28.56
- Victoza (Drug) $27.78
- INVOKANA (Drug) $26.95
- BELSOMRA (Drug) $26.92
- CHANTIX (Drug) $23.86
- Prolastin-C (Biological) $21.72
- ANORO (Drug) $21.29
- GATTEX (Drug) $18.58
- Aimovig (Biological) $18.33
- TRADJENTA (Drug) $18.10
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Kalispell
Dr. Nathan Bingham, M.d., Phd, M.D., PHD
Pediatrics — Payments: $1,770
Douglas Nelson, M.d, M.D
Pediatrics — Payments: $1,057
Jennifer Shipley, Pnp, PNP
Pediatrics — Payments: $384.99
Daniel Hanba, Md, MD
Pediatrics — Payments: $301.64
Dr. Allie Maffit, M.d, M.D
Pediatrics — Payments: $123.12
Kenneth Graham, Md, MD
Pediatrics — Payments: $100.00